News for hackers. Stuff that matters.

A comment on Subprime ‘unicorns’ that do not look a billion dollars. Parent comment

Re:Subprime ‘unicorns’ that do not look a billion dollars by dbcooper on Saturday October 17, 2015 @03:14AM (#10403671)
Abaxis (manufacturers of the "Piccolo" systems, which seem to be lab-on-disc based and offer point-of-care operation) are an interesting company to compare to Theranos. They seem to be able to perform small panels of assays (up to 14) on 100 µL samples [1] obtained by venipuncture.[2]

They are valued at $880M, and had ~ $200M revenue and $27M profit in the last financial year.

http://www.abaxis.com/about_us/history.html

[1] http://www.piccoloxpress.com/products/panels/function/

[2] http://www.piccoloxpress.com/wp-content/uploads/2015Revision...

[ Parent | on HN ]
Re:Subprime ‘unicorns’ that do not look a billion dollars by AndrewKemendo on Saturday October 17, 2015 @03:49PM (#10405787)
They are valued at $880M, and had ~ $200M revenue and $27M profit in the last financial year.

If they were in startup world those numbers would probably make them over $1BN in valuation.

[ Parent | on HN ]
Re:Subprime ‘unicorns’ that do not look a billion dollars by pbreit on Saturday October 17, 2015 @06:03PM (#10406325)
Only if they are growing rapidly.
[ Parent | on HN ]